| abstract |
The present invention relates to a transdermal absorption preparation of an antidementia drug with little skin irritation. More specifically, the present invention relates to a drug comprising an anti-dementia therapeutic drug, a polymer compound having an amino group, a polyhydric alcohol fatty acid ester, a polyhydric alcohol, a polycarboxylic acid ester, and a styrenic polymer compound. The present invention relates to a percutaneously absorbable preparation comprising a containing layer, wherein the content of an antidementia drug is 0.5 to 20% by mass of the drug containing layer. |